Search
01/01/2024
Defective insulin-stimulated equilibrative nucleoside transporter-2 activity and altered subcellular transporter distribution drive the loss of adenosine homeostasis in diabetic kidney disease progression.
Suarez R, Villarreal C, Nahuelpán Y, Jara C, Oyarzún C, Alarcón S, Díaz-Encarnación MM, Guillén-Gómez E, Quezada C, San Martín R. Defective insulin-stimulated equilibrative nucleoside transporter-2 activity and altered subcellular transporter distribution drive the loss of adenosine homeostasis in diabetic kidney disease progression.. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2024; 1870(1)DOI:10.1016/j.bbadis.2023.166890. PMID:37734469. IF:4.200(Q1/2D).
01/01/2024
One-year outcomes after discharge from noncardiac surgery and association between pre-discharge complications and death after discharge: analysis of the VISION prospective cohort study.
Roshanov PS, Chan MTV, Borges FK, Conen D, Wang CY, Xavier D, Berwanger O, Marcucci M, Sessler DI, Szczeklik W, Spence J, Alonso-Coello P, Fernández C, Pearse RM, Malaga G, Garg AX, Srinathan SK, Jacka MJ, Tandon V, McGillion M, Popova E, Sigamani A, Abraham V, Biccard BM, Villar JC, Chow CK, Polanczyk CA, Tiboni M, Whitlock R, Ackland GL, Panju M, Lamy A, Sapsford R, Williams C, Wu WKK, Cortés OL, MacNeil SD, Patel A, Belley-Côté EP, Ofori S, McIntyre WF, Leong DP, Heels-Ansdell D, Gregus K, Devereaux PJ. One-year outcomes after discharge from noncardiac surgery and association between pre-discharge complications and death after discharge: analysis of the VISION prospective cohort study.. ANESTHESIOLOGY. 2024; 140(1)DOI:10.1097/ALN.0000000000004763. PMID:37713506. IF:9.100(Q1/1D).
01/01/2024
Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.
Vilarrasa E, Nicolau J, de la Cueva P, Goday A, Gallardo F, Martorell A, Carrascosa JM. Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.. Actas Dermo-Sifiliograficas. 2024; 115(1)DOI:10.1016/j.ad.2023.06.017. PMID:37451337. IF:(Q/D).
01/01/2024
Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant
Cabezón-Villalba G., Barge-Caballero E., González-Vílchez F., Castel-Lavilla M.Á., Gómez-Bueno M., Almenar-Bonet L., González-Costello J., Lambert-Rodríguez J.L., Martínez-Sellés M., de la Fuente-Galán L., Mirabet-Pérez S., García-Cosío Carmena M.D., Hervás-Sotomayor D., Rangel-Sousa D., Blasco-Peiró T., Garrido-Bravo I.P., Rábago Juan-Aracil G., Muñiz J., Crespo-Leiro M.G.. Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant. REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(1)DOI:10.1016/j.recesp.2023.05.001. PMID:. IF:(Q/D).